Avomeen, an accredited independent contract research organization and contract development and manufacturing organization in Ann Arbor, announced Alex Garner as its new director of formulation and clinical trial manufacturing.
In his new role, Garner will further expand and strengthen the company’s formulation and clinical trial manufacturing capabilities to support biopharmaceutical clients whose product portfolios include both small- and large-molecule therapies.
“Alex brings a wealth of knowledge and expertise in chemistry, manufacturing, and controls (CMC) strategy, process and formulation development, clinical trial batch manufacturing, and packing and documentation,” says Mark Harvill, CEO of Avomeen.
“His leadership, along with his extensive CMC and formulation knowledge, will help us expand this business segment to ensure Avomeen is positioned to provide comprehensive, full-service formulation and manufacturing support to clients in both small- and large-molecule development.”
Most recently, he served as a pharmaceutical development scientist at Metrics Contract Services where he supervised manufacturing specialists and scientists while serving as the primary point of contact for clients regarding development and clinical trial manufacturing.
Garner hold a master’s degree in chemistry and a bachelor’s degree in chemistry and history from East Carolina University.